Cash flow Agilent Technologies, Inc.

Equities

A

US00846U1016

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 04:00:02 2025-07-11 pm EDT			5-day change	1st Jan Change
123.28 ^USD	-0.72%		+1.57%	-8.23%

Jul. 08	Agilent Technologies, Inc., Q2 2025 Earnings Call, May 28, 2025
Jul. 08	Evercore ISI Adjusts Price Target on Agilent Technologies to $130 From $125, Maintains In Line Rating	MT

04fc49fef713a0133.MGz9RIvia43_NDACWBWJTdTKKPvVdwnSExr9AgWmL5I.YCGuNNypEtyrQkhHHiPsH4H_RK6RDzC3J3KYMG6fXKEJGrw33LEy3q8NVw

Published financial data: AGILENT TECHNOLOGIES, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: October	2020	2021	2022	2023	2024
Revenues	5.34B	6.32B	6.85B	6.83B	6.51B
Total Revenues	5.34B	6.32B	6.85B	6.83B	6.51B
Cost of Goods Sold, Total	2.5B	2.91B	3.13B	3.37B	2.98B
Gross Profit	2.84B	3.41B	3.72B	3.46B	3.54B
Selling General & Admin Expenses, Total	1.4B	1.56B	1.58B	1.58B	1.52B
R&D Expenses	397M	441M	467M	481M	473M
Other Operating Expenses, Total	1.79B	2B	2.04B	2.06B	1.99B
Operating Income	1.04B	1.4B	1.68B	1.41B	1.54B
Interest Expense, Total	-78M	-81M	-84M	-95M	-96M
Interest And Investment Income	8M	2M	9M	51M	80M
Net Interest Expenses	-70M	-79M	-75M	-44M	-16M
Income (Loss) On Equity Invest.	-	-	-	-	-
Currency Exchange Gains (Loss)	-4M	-4M	-6M	-2M	-4M
Other Non Operating Income (Expenses)	15M	15M	14M	62M	20M
EBT, Excl. Unusual Items	986M	1.34B	1.61B	1.42B	1.54B
Restructuring Charges	-151M	-37M	-30M	-25M	-11M
Merger & Related Restructuring Charges	-41M	-41M	-25M	-16M	-12M
Gain (Loss) On Sale Of Investments	26M	98M	-67M	-41M	6M
Asset Writedown	-	-	-	-	-6M
Legal Settlements	22M	-	-	-	-
Other Unusual Items	-	4M	16M	-1M	-
EBT, Incl. Unusual Items	842M	1.36B	1.5B	1.34B	1.52B
Income Tax Expense	123M	150M	250M	99M	232M
Earnings From Continuing Operations	719M	1.21B	1.25B	1.24B	1.29B
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	719M	1.21B	1.25B	1.24B	1.29B
Net Income - (IS)	719M	1.21B	1.25B	1.24B	1.29B
Net Income to Common Incl Extra Items	719M	1.21B	1.25B	1.24B	1.29B
Net Income to Common Excl. Extra Items	719M	1.21B	1.25B	1.24B	1.29B
Per Share Items
Net EPS - Basic	2.33	3.98	4.19	4.22	4.44
Basic EPS - Continuing Operations	2.33	3.98	4.19	4.22	4.44
Basic Weighted Average Shares Outstanding	309M	304M	299M	294M	290M
Net EPS - Diluted	2.3	3.94	4.18	4.19	4.43
Diluted EPS - Continuing Operations	2.3	3.94	4.18	4.19	4.43
Diluted Weighted Average Shares Outstanding	312M	307M	300M	296M	291M
Normalized Basic EPS	1.99	2.75	3.37	3.02	3.33
Normalized Diluted EPS	1.98	2.72	3.35	3	3.32
Dividend Per Share	0.72	0.78	0.84	0.9	0.94
Payout Ratio	30.88	19.5	19.94	21.37	21.26
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	1.35B	1.72B	1.99B	1.68B	1.8B
EBITA	1.23B	1.6B	1.87B	1.55B	1.65B
EBIT	1.04B	1.4B	1.68B	1.41B	1.54B
EBITDAR	1.41B	1.79B	2.06B	1.75B	1.86B
Total Revenues (As Reported)	5.34B	6.32B	6.85B	6.83B	6.51B
Effective Tax Rate - (Ratio)	14.61	11.03	16.62	7.39	15.25
Current Domestic Taxes	10M	139M	195M	129M	209M
Current Foreign Taxes	84M	-3M	47M	26M	87M
Total Current Taxes	94M	136M	242M	155M	296M
Deferred Domestic Taxes	5M	0	-27M	-94M	-124M
Deferred Foreign Taxes	24M	14M	35M	38M	60M
Total Deferred Taxes	29M	14M	8M	-56M	-64M
Normalized Net Income	616M	835M	1.01B	889M	965M
Interest on Long-Term Debt	78M	81M	84M	-	-
Non-Cash Pension Expense	4M	2M	-18M	-8M	-23M
Supplemental Operating Expense Items
Advertising Expense	48M	63M	66M	54M	49M
Selling and Marketing Expenses	-	-	-	-	49M
Research And Development Expense From Footnotes	495M	441M	467M	481M	479M
Net Rental Expense, Total	61M	62M	62M	70M	56M
Imputed Operating Lease Interest Expense	15.4M	14.75M	14.29M	18.28M	13.29M
Imputed Operating Lease Depreciation	45.6M	47.25M	47.71M	51.72M	42.71M
Stock-Based Comp., COGS (Total)	21M	26M	30M	34M	41M
Stock-Based Comp., R&D Exp. (Total)	9M	12M	14M	13M	16M
Stock-Based Comp., SG&A Exp. (Total)	54M	73M	82M	65M	73M
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	84M	111M	126M	112M	130M

Fiscal Period: October	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	1.44B	1.48B	1.05B	1.59B	1.33B
Short Term Investments	-	91M	-	-	-
Total Cash And Short Term Investments	1.44B	1.58B	1.05B	1.59B	1.33B
Accounts Receivable, Total	1.04B	1.17B	1.4B	1.29B	1.32B
Other Receivables	89M	66M	87M	100M	147M
Total Receivables	1.13B	1.24B	1.49B	1.39B	1.47B
Inventory	720M	830M	1.04B	1.03B	972M
Deferred Tax Assets Current	-	-	-	-	-
Restricted Cash	-	-	-	-	-
Other Current Assets, Total	127M	156M	195M	174M	187M
Total Current Assets	3.42B	3.8B	3.78B	4.19B	3.96B
Gross Property Plant And Equipment	2.05B	2.24B	2.4B	2.65B	3.26B
Accumulated Depreciation	-1.03B	-1.12B	-1.15B	-1.22B	-1.3B
Net Property Plant And Equipment	1.02B	1.12B	1.25B	1.42B	1.96B
Long-term Investments	158M	185M	195M	164M	175M
Goodwill	3.6B	3.98B	3.95B	3.96B	4.48B
Other Intangibles, Total	831M	981M	821M	475M	547M
Deferred Tax Assets Long-Term	380M	309M	246M	284M	351M
Other Long-Term Assets, Total	221M	333M	290M	270M	382M
Total Assets	9.63B	10.7B	10.53B	10.76B	11.85B
Liabilities
Accounts Payable, Total	354M	446M	580M	418M	540M
Accrued Expenses, Total	491M	626M	580M	529M	530M
Short-term Borrowings	75M	-	36M	-	45M
Current Portion of Long-Term Debt	-	-	-	-	-
Current Portion of Leases	51M	52M	52M	46M	42M
Current Income Taxes Payable	63M	47M	51M	73M	152M
Unearned Revenue Current, Total	386M	441M	461M	505M	544M
Deferred Tax Liability Current	-	-	-	-	-
Other Current Liabilities	47M	96M	101M	32M	42M
Total Current Liabilities	1.47B	1.71B	1.86B	1.6B	1.9B
Long-Term Debt	2.28B	2.73B	2.73B	2.74B	3.34B
Long-Term Leases	127M	130M	101M	118M	142M
Unearned Revenue Non Current	60M	78M	96M	111M	157M
Pension & Other Post Retirement Benefits	389M	220M	97M	103M	130M
Deferred Tax Liability Non Current	24M	103M	58M	38M	85M
Other Non Current Liabilities	403M	348M	281M	210M	194M
Total Liabilities	4.75B	5.32B	5.23B	4.92B	5.95B
Common Stock, Total	3M	3M	3M	3M	3M
Additional Paid In Capital	5.31B	5.32B	5.32B	5.39B	5.45B
Retained Earnings	81M	348M	324M	782M	750M
Treasury Stock	-	-	-	-	-
Comprehensive Income and Other	-522M	-282M	-347M	-327M	-305M
Total Common Equity	4.87B	5.39B	5.3B	5.84B	5.9B
Minority Interest	-	-	-	-	-
Total Equity	4.87B	5.39B	5.3B	5.84B	5.9B
Total Liabilities And Equity	9.63B	10.7B	10.53B	10.76B	11.85B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	307M	302M	296M	293M	286M
ECS Total Common Shares Outstanding	306M	302M	295M	292M	285M
Book Value / Share	15.91	17.83	17.97	20.01	20.68
Tangible Book Value	440M	433M	532M	1.41B	874M
Tangible Book Value Per Share	1.44	1.43	1.8	4.83	3.06
Total Debt	2.54B	2.91B	2.92B	2.9B	3.57B
Net Debt	1.1B	1.34B	1.87B	1.31B	2.24B
Debt Equivalent of Unfunded Proj. Benefit Obligation	220M	-32M	-122M	-125M	-193M
Debt Equivalent Oper. Leases	488M	496M	496M	560M	448M
Minority Interest, Total (Incl. Fin. Div)	-	-	-	-	-
Equity Method Investments, Total	-	-	-	-	-
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	303M	367M	483M	461M	449M
Inventories - Finished Goods, Total	417M	463M	555M	570M	523M
Land - (BS)	58M	61M	59M	60M	69M
Buildings, Total	1.06B	1.15B	1.26B	1.41B	1.79B
Machinery, Total	579M	638M	674M	749M	960M
Full Time Employees	16.4K	17K	18.1K	18.1K	17.9K

Fiscal Period: October	2020	2021	2022	2023	2024
Net Income	719M	1.21B	1.25B	1.24B	1.29B
Depreciation & Amortization - CF	122M	126M	125M	131M	152M
Amortization of Goodwill and Intangible Assets - (CF)	186M	195M	192M	140M	105M
Depreciation & Amortization, Total	308M	321M	317M	271M	257M
(Gain) Loss From Sale Of Asset	-	-	-	-43M	-
(Gain) Loss on Sale of Investments - (CF)	-28M	-98M	67M	41M	-6M
Asset Writedown & Restructuring Costs	99M	2M	-	277M	19M
Stock-Based Compensation (CF)	83M	110M	125M	111M	129M
Tax Benefit from Stock Options	-	-	-	-	-
Net Cash From Discontinued Operations	-	-	-	-	-
Other Operating Activities, Total	65M	42M	27M	-9M	-20M
Change In Accounts Receivable	-107M	-128M	-321M	132M	7M
Change In Inventories	-68M	-136M	-248M	-33M	34M
Change In Accounts Payable	2M	64M	121M	-171M	103M
Change In Income Taxes	-	-	-	-	-
Change in Other Net Operating Assets	-152M	98M	-30M	-44M	-61M
Cash from Operations	921M	1.48B	1.31B	1.77B	1.75B
Capital Expenditure	-119M	-188M	-291M	-298M	-378M
Sale of Property, Plant, and Equipment	1M	1M	-	-	-
Cash Acquisitions	-	-546M	-52M	-51M	-862M
Divestitures	-	-	-	50M	-
Sale (Purchase) of Intangible assets	-	-1M	-	-	-
Investment in Marketable and Equity Securities, Total	-20M	-10M	9M	-3M	-5M
Other Investing Activities, Total	-9M	-5M	-4M	-8M	-13M
Cash from Investing	-147M	-749M	-338M	-310M	-1.26B
Short Term Debt Issued, Total	1.22B	1.65B	1.3B	-	40M
Long-Term Debt Issued, Total	499M	848M	600M	-	1.2B
Total Debt Issued	1.72B	2.5B	1.9B	-	1.24B
Short Term Debt Repaid, Total	-345M	-1.72B	-1.26B	-35M	-
Long-Term Debt Repaid, Total	-1.42B	-417M	-609M	-	-600M
Total Debt Repaid	-1.76B	-2.14B	-1.87B	-35M	-600M
Issuance of Common Stock	60M	55M	58M	67M	77M
Repurchase of Common Stock	-506M	-864M	-1.21B	-629M	-1.18B
Common Dividends Paid	-222M	-236M	-250M	-265M	-274M
Common & Preferred Stock Dividends Paid	-222M	-236M	-250M	-265M	-274M
Other Financing Activities, Total	-4M	-7M	-	-68M	-9M
Cash from Financing	-717M	-696M	-1.37B	-930M	-752M
Foreign Exchange Rate Adjustments	2M	3M	-36M	5M	-2M
Net Change in Cash	59M	43M	-434M	537M	-261M
Supplemental Items
Cash Interest Paid	71M	76M	85M	89M	80M
Cash Income Tax Paid (Refund)	361M	211M	279M	199M	314M
Levered Free Cash Flow	587M	1.13B	764M	816M	1.13B
Unlevered Free Cash Flow	636M	1.19B	816M	876M	1.19B
Change In Net Working Capital	290M	-65M	384M	88M	-217M
Net Debt Issued / Repaid	-45M	356M	26M	-35M	637M

Fiscal Period: October	2020	2021	2022	2023	2024
Profitability
Return on Assets	6.85	8.63	9.87	8.25	8.54
Return on Total Capital	8.97	11.17	12.68	10.36	10.6
Return On Equity %	14.95	23.58	23.45	22.24	21.95
Return on Common Equity	14.95	23.58	23.45	22.24	21.95
Margin Analysis
Gross Profit Margin %	53.14	53.92	54.35	50.71	54.3
SG&A Margin	26.13	24.72	23.04	23.09	23.32
EBITDA Margin %	25.34	27.3	29.12	24.54	27.67
EBITA Margin %	23.06	25.3	27.29	22.63	25.33
EBIT Margin %	19.57	22.22	24.49	20.58	23.72
Income From Continuing Operations Margin %	13.47	19.15	18.31	18.15	19.8
Net Income Margin %	13.47	19.15	18.31	18.15	19.8
Net Avail. For Common Margin %	13.47	19.15	18.31	18.15	19.8
Normalized Net Income Margin	11.54	13.21	14.69	13.01	14.82
Levered Free Cash Flow Margin	11	17.96	11.15	11.95	17.37
Unlevered Free Cash Flow Margin	11.91	18.76	11.92	12.82	18.29
Asset Turnover
Asset Turnover	0.56	0.62	0.64	0.64	0.58
Fixed Assets Turnover	5.71	5.9	5.77	5.11	3.85
Receivables Turnover (Average Receivables)	5.43	5.72	5.31	5.07	4.98
Inventory Turnover (Average Inventory)	3.58	3.76	3.35	3.26	2.97
Short Term Liquidity
Current Ratio	2.33	2.22	2.03	2.61	2.09
Quick Ratio	1.75	1.65	1.37	1.86	1.48
Operating Cash Flow to Current Liabilities	0.63	0.87	0.7	1.11	0.92
Days Sales Outstanding (Average Receivables)	67.46	63.83	68.68	72.01	73.51
Days Outstanding Inventory (Average Inventory)	102.32	97.14	109.06	112.11	123.21
Average Days Payable Outstanding	50.95	48.31	56.16	54.19	60.12
Cash Conversion Cycle (Average Days)	118.83	112.66	121.57	129.93	136.6
Long Term Solvency
Total Debt/Equity	52.06	54.02	55.08	49.6	60.6
Total Debt / Total Capital	34.24	35.07	35.52	33.15	37.73
LT Debt/Equity	49.48	53.05	53.42	48.81	59.12
Long-Term Debt / Total Capital	32.54	34.45	34.45	32.63	36.81
Total Liabilities / Total Assets	49.38	49.66	49.63	45.69	50.21
EBIT / Interest Expense	13.4	17.33	19.96	14.8	16.08
EBITDA / Interest Expense	18.13	22.06	24.48	18.39	19.34
(EBITDA - Capex) / Interest Expense	16.6	19.74	21.01	15.25	15.41
Total Debt / EBITDA	1.79	1.63	1.42	1.66	1.92
Net Debt / EBITDA	0.78	0.75	0.91	0.75	1.21
Total Debt / (EBITDA - Capex)	1.96	1.82	1.66	2	2.42
Net Debt / (EBITDA - Capex)	0.85	0.84	1.06	0.9	1.52
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	3.41	18.36	8.37	-0.22	-4.73
Gross Profit, 1 Yr. Growth %	1.14	20.09	9.25	-6.9	2.02
EBITDA, 1 Yr. Growth %	5.62	27.49	15.59	-15.9	6.82
EBITA, 1 Yr. Growth %	5.12	29.89	16.89	-17.28	6.04
EBIT, 1 Yr. Growth %	0.19	34.35	19.44	-16.16	9.12
Earnings From Cont. Operations, 1 Yr. Growth %	-32.87	68.29	3.64	-1.12	3.95
Net Income, 1 Yr. Growth %	-32.87	68.29	3.64	-1.12	3.95
Normalized Net Income, 1 Yr. Growth %	-2.95	35.63	20.51	-11.68	11.24
Diluted EPS Before Extra, 1 Yr. Growth %	-31.75	71.3	6.09	0.24	5.73
Accounts Receivable, 1 Yr. Growth %	11.61	12.91	19.88	-8.11	2.56
Inventory, 1 Yr. Growth %	6.04	15.28	25.06	-0.67	-5.72
Net Property, Plant and Equip., 1 Yr. Growth %	20	10.1	11.31	13.92	37.29
Total Assets, 1 Yr. Growth %	1.85	11.2	-1.62	2.19	10.06
Tangible Book Value, 1 Yr. Growth %	816.67	-1.59	22.86	165.04	-38.01
Common Equity, 1 Yr. Growth %	2.63	10.59	-1.56	10.18	0.91
Cash From Operations, 1 Yr. Growth %	-9.79	61.24	-11.65	35.06	-1.19
Capital Expenditures, 1 Yr. Growth %	-23.23	57.98	54.79	2.41	26.85
Levered Free Cash Flow, 1 Yr. Growth %	-30.62	93.21	-32.77	6.77	37.59
Unlevered Free Cash Flow, 1 Yr. Growth %	-28.76	86.36	-31.22	7.17	35.13
Dividend Per Share, 1 Yr. Growth %	9.76	7.78	8.25	7.14	4.89
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	4.23	10.63	13.25	3.99	-2.5
Gross Profit, 2 Yr. CAGR %	2.89	10.21	14.54	0.85	-2.54
EBITDA, 2 Yr. CAGR %	7.03	16.04	21.4	-1.4	-4.96
EBITA, 2 Yr. CAGR %	6.71	16.85	23.22	-1.67	-6.07
EBIT, 2 Yr. CAGR %	3.74	16.02	26.68	0.07	-4.05
Earnings From Cont. Operations, 2 Yr. CAGR %	50.84	6.29	32.06	1.23	1.39
Net Income, 2 Yr. CAGR %	50.84	6.29	32.06	1.23	1.39
Normalized Net Income, 2 Yr. CAGR %	1.4	14.67	27.85	3.17	-2.07
Diluted EPS Before Extra, 2 Yr. CAGR %	53.98	8.13	34.81	3.12	2.95
Accounts Receivable, 2 Yr. CAGR %	15.66	12.26	16.34	4.95	-2.93
Inventory, 2 Yr. CAGR %	6.23	10.56	20.07	11.45	-3.23
Net Property, Plant and Equip., 2 Yr. CAGR %	11.39	14.94	10.7	12.61	25.06
Total Assets, 2 Yr. CAGR %	6.17	6.42	4.59	0.27	6.05
Tangible Book Value, 2 Yr. CAGR %	-36.84	200.35	9.96	80.45	28.17
Common Equity, 2 Yr. CAGR %	3.3	6.54	4.34	4.14	5.44
Cash From Operations, 2 Yr. CAGR %	-7.95	20.6	19.35	9.24	15.52
Capital Expenditures, 2 Yr. CAGR %	-18.01	10.13	56.38	25.9	13.97
Levered Free Cash Flow, 2 Yr. CAGR %	-6.51	15.78	14.02	-15.22	21.62
Unlevered Free Cash Flow, 2 Yr. CAGR %	-5.93	15.23	13.27	-14.09	20.73
Dividend Per Share, 2 Yr. CAGR %	9.91	8.76	8.01	7.69	6.01
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	6.08	8.74	9.87	8.57	1
Gross Profit, 3 Yr. CAGR %	5.75	8.33	9.89	6.89	1.24
EBITDA, 3 Yr. CAGR %	8.31	13.46	15.89	7.42	1.45
EBITA, 3 Yr. CAGR %	8.16	13.94	16.86	7.89	1.03
EBIT, 3 Yr. CAGR %	7	13.08	17.15	10.4	3.22
Earnings From Cont. Operations, 3 Yr. CAGR %	1.68	56.45	5.4	19.92	2.13
Net Income, 3 Yr. CAGR %	1.68	56.45	5.4	19.92	2.13
Normalized Net Income, 3 Yr. CAGR %	6.55	11.69	16.59	13.02	4.94
Diluted EPS Before Extra, 3 Yr. CAGR %	3.08	59.55	7.44	22.13	3.98
Accounts Receivable, 3 Yr. CAGR %	12.76	14.73	14.74	7.54	4.15
Inventory, 3 Yr. CAGR %	7.78	9.17	15.2	12.71	5.41
Net Property, Plant and Equip., 3 Yr. CAGR %	10.45	10.96	13.72	11.76	20.3
Total Assets, 3 Yr. CAGR %	4.54	7.82	3.67	3.79	3.43
Tangible Book Value, 3 Yr. CAGR %	-38.19	-26.78	122.96	47.43	26.38
Common Equity, 3 Yr. CAGR %	0.29	5.67	3.77	6.25	3.05
Cash From Operations, 3 Yr. CAGR %	1.19	10.96	8.72	24.38	5.65
Capital Expenditures, 3 Yr. CAGR %	-12.23	2.03	23.36	35.8	26.22
Levered Free Cash Flow, 3 Yr. CAGR %	2.61	19.09	-3.38	11.6	-0.14
Unlevered Free Cash Flow, 3 Yr. CAGR %	2.36	18.15	-2.95	11.24	0.13
Dividend Per Share, 3 Yr. CAGR %	10.89	9.2	8.59	7.72	6.75
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	5.74	8.5	8.9	6.82	4.75
Gross Profit, 5 Yr. CAGR %	6.81	9.17	9.18	5.27	4.73
EBITDA, 5 Yr. CAGR %	11.7	12.81	13.36	7.26	7.05
EBITA, 5 Yr. CAGR %	12.5	13.42	13.95	7.42	7.09
EBIT, 5 Yr. CAGR %	14.76	15	14.48	7.68	8.16
Earnings From Cont. Operations, 5 Yr. CAGR %	10.42	21.24	12.89	31.45	3.78
Net Income, 5 Yr. CAGR %	12.39	21.24	12.89	31.45	3.78
Normalized Net Income, 5 Yr. CAGR %	15.34	15.68	14.59	8.2	8.73
Diluted EPS Before Extra, 5 Yr. CAGR %	11.92	22.99	14.76	34	5.62
Accounts Receivable, 5 Yr. CAGR %	11.36	13.18	14.18	10.72	7.32
Inventory, 5 Yr. CAGR %	5.88	9.26	12.54	10.07	7.44
Net Property, Plant and Equip., 5 Yr. CAGR %	11.05	11.94	10.55	11.62	18.13
Total Assets, 5 Yr. CAGR %	5.18	6.55	4.56	4.73	4.62
Tangible Book Value, 5 Yr. CAGR %	-20.16	-19.86	-22.17	5.03	78.67
Common Equity, 5 Yr. CAGR %	3.18	4.9	1.89	5.06	4.43
Cash From Operations, 5 Yr. CAGR %	-6.97	13.37	8.1	10.27	11.39
Capital Expenditures, 5 Yr. CAGR %	3.96	6.23	10.58	10.98	19.52
Levered Free Cash Flow, 5 Yr. CAGR %	-15.81	5.6	7.03	3.97	5.96
Unlevered Free Cash Flow, 5 Yr. CAGR %	-14.96	5.45	6.59	4.03	5.93
Dividend Per Share, 5 Yr. CAGR %	12.47	11.02	9.73	8.59	7.55